3/21/2024 | BK | Baxter International amends three credit facilities led by JPMorgan
|
1/4/2024 | BKIG | Fitch trims Baxter's Ratings
|
10/18/2023 | SP | New Issue: JPMorgan prices $46,000 9.4% autocallable contingent interest notes linked to Baxter
|
1/9/2023 | BKIG | Fitch puts Baxter on watch
|
9/30/2022 | BK | Baxter International amends credit facilities for benchmark change
|
8/22/2022 | BKIG | Fitch alters Baxter outlook to negative
|
8/12/2022 | BK | S&P moves Baxter view to negative
|
12/16/2021 | BKIG | S&P cuts Baxter
|
12/16/2021 | BKIG | Moody's downgrades Baxter
|
12/15/2021 | BKIG | Fitch downgrades Baxter
|
11/17/2021 | IG | New Issue: Baxter sells $7.8 billion of bonds in eight parts for Hill-Rom buy
|
11/16/2021 | IG | Baxter International readies eight-part Hill-Rom acquisition bonds
|
11/15/2021 | BKIG | Fitch rates Baxter notes A-
|
11/15/2021 | BKIG | Moody's assigns Baxter notes Baa2
|
11/15/2021 | BKIG | S&P gives Baxter notes A-
|
10/4/2021 | BK | Baxter International gets $4 billion term loan, $2.5 billion revolver
|
9/2/2021 | BKIG | Fitch puts Baxter on watch
|
9/2/2021 | BKIG | Moody's eyes Baxter for downgrade
|
9/2/2021 | BKIG | S&P puts Baxter on watch
|
9/2/2021 | BKIG | Baxter gets $11.4 billion bridge loan commitment for Hillrom buy
|
10/29/2020 | EMHYPFPV | Market Commentary: Boeing, Philip Morris, Black & Decker, Baxter price; supply strong
|
10/29/2020 | IG | Market Commentary: Boeing, Philip Morris, Black & Decker, Baxter price; supply strong; high-grade flows slow
|
10/29/2020 | IG | New Issue: Baxter prices $650 million of 1.73% notes due 2031 at 90 bps spread
|
10/29/2020 | IG | Market Commentary: Morning Commentary: Boeing, Philip Morris, Stanley Black & Decker, Baxter market notes
|
10/29/2020 | IG | Baxter International talks $650 million of notes due 2031 at Treasuries plus 115 bps area
|
10/29/2020 | IG | Baxter International offers $650 million secured notes due 2031
|
10/29/2020 | BKIG | Fitch gives Baxter notes A-
|
10/29/2020 | IGLM | Baxter International to redeem $750 million 3.75% notes due 2025
|
10/29/2020 | BKIG | Moody’s assigns Baxter notes Baa1
|
10/29/2020 | BKIG | S&P gives Baxter notes A-
|
3/24/2020 | IG | Market Commentary: High-grade supply surges; Comcast, Lowe’s, MasterCard, Citi, Baxter, Kimberly-Clark price
|
3/24/2020 | EMHYPFPV | Market Commentary: High-grade supply surges; Comcast, Lowe’s, MasterCard, Citi, Baxter, Kimberly-Clark price
|
3/24/2020 | IG | New Issue: Baxter International prices $1.25 billion of notes due 2025, 2030
|
3/24/2020 | BKIG | Fitch gives A- to Baxter notes
|
3/24/2020 | BKIG | Moody's assigns Baxter notes Baa1
|
3/24/2020 | BKIG | S&P rates Baxter notes A-
|
12/20/2019 | BK | Baxter gets $2 billion five-year revolver, €200 million revolver
|
4/2/2018 | SP | New Issue: CIBC sells $285,000 Raymond James Healthcare Top Selections notes on 16 stocks
|
4/2/2018 | BKIG | Fitch upgrades Baxter to A-
|
3/29/2018 | BKIG | Moody’s upgrades Baxter to Baa1
|
3/20/2018 | SP | CIBC plans Raymond James Healthcare Top Selections notes on 16 stocks
|
3/20/2018 | SP | CIBC to price notes on 16 Raymond James top pick healthcare stocks
|
10/10/2017 | SP | New Issue: JPMorgan sells $5.7 million digital variable coupon notes linked to nine stocks
|
9/28/2017 | SP | JPMorgan pushes back pricing on digital notes linked to nine stocks
|
9/25/2017 | SP | JPMorgan to price digital variable coupon notes linked to nine stocks
|
5/19/2017 | BKIG | S&P gives A- to Baxter notes
|
5/19/2017 | BKIG | Fitch applies BBB+ to Baxter notes
|
5/19/2017 | BKIG | Moody’s rates Baxter notes Baa2
|
8/11/2016 | IG | New Issue: Baxter International prices $1.6 billion of senior notes due 2021, 2026, 2046
|
8/10/2016 | EMHYMUPFPV | Market Commentary: Amgen, FMS, Baxter among high-grade issuers; credit spreads soften; Duke Energy bonds improve
|
8/10/2016 | IG | Market Commentary: Amgen, FMS, Baxter among high-grade issuers; credit spreads soften; Duke Energy bonds improve
|
8/10/2016 | IG | New Issue: Baxter International sells $1.6 billion of senior notes in three parts
|
8/10/2016 | BKIG | Moody’s applies Baa2 to Baxter notes
|
8/10/2016 | BKIG | Fitch rates Baxter notes BBB+
|
8/10/2016 | BKIG | S&P rates Baxter notes A-
|
8/10/2016 | IG | Baxter International to price senior notes due 2021, 2026, 2046
|
5/13/2016 | BKIG | S&P changes Baxter view to stable
|
3/1/2016 | IGLM | Baxter tender pricing announced, offer raised to $2.2 billion by banks
|
3/1/2016 | IGLM | Baxter tender raised to $2.2 billion by banks; early results revealed
|
2/2/2016 | BK | Baxter repays, terminates 364-day revolver via stock transfer to lender
|
12/31/2015 | LM | Market Commentary: Outlook 2016: AIG, KazMunay Gas, Hewlett-Packard in big deals; commodity pricing has impact
|
12/9/2015 | BK | Baxter International amends termination date of 364-day facility
|
7/7/2015 | BK | Baxter gets $1.5 billion five-year revolver, €200 million revolver
|
7/2/2015 | IGLM | Baxter holders tender $2.7 billion notes in any and all, capped offers
|
7/1/2015 | IGLM | Baxter prices tender offers for any and all, maximum of seven series
|
6/18/2015 | IGLM | Baxter tenders for any and all of five series, maximum of two series
|
5/29/2015 | BKIG | Fitch downgrades Baxter
|
5/27/2015 | BKIG | Moody’s drops Baxter to Baa2
|
5/11/2015 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
3/27/2015 | BKIG | Moody’s might cut Baxter
|
3/9/2015 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
12/16/2014 | BK | Baxter International enters into $1.8 billion 364-day credit facility
|
10/27/2014 | BKIG | S&P keeps Baxter on watch
|
7/17/2014 | BK | Baxter International amends loan agreement, extends to Dec. 31, 2015
|
3/27/2014 | BKCVIG | S&P downgrades Baxter
|
3/27/2014 | BKCVIG | Fitch: Baxter on negative watch
|
3/27/2014 | BKIG | Baxter plans tax-free spinoff to create two separate global health-care companies
|
3/27/2014 | BKIG | Moody's: Baxter view to negative
|
9/9/2013 | BKIG | Fitch: Baxter view negative
|
6/4/2013 | IG | Market Commentary: Baxter sells to fund acquisition; Allstate, SEK tap market; recent deals mixed in secondary
|
6/4/2013 | BKIG | Moody's rates Baxter notes A3
|
6/4/2013 | BKIG | Fitch rates Baxter bond A
|
6/4/2013 | BKIG | S&P assigns A to Baxter notes
|
6/4/2013 | IG | Baxter sets talk, to price senior notes in five tranches Tuesday
|
6/4/2013 | IG | New Issue: Baxter sells $3.5 billion of senior notes in five tranches
|
1/29/2013 | BKIG | Baxter International gets $3.1 billion bridge loan for Indap purchase
|
12/6/2012 | CVIG | S&P downgrades Baxter
|
12/5/2012 | CVIG | Fitch puts Baxter on watch
|
12/4/2012 | CVIG | Baxter to use overseas cash, new debt to fund Gambro AB acquisition
|
12/4/2012 | CVIG | Moody's could cut Baxter
|
8/8/2012 | CVIG | Fitch rates Baxter notes A
|
8/8/2012 | CVIG | Moody's: Baxter notes A3
|
8/8/2012 | IG | New Issue: Baxter International sells upsized $1 billion of 10-, 30-year notes
|
8/8/2012 | IG | Market Commentary: PepsiCo, Kinder Morgan, Baxter, MetLife among deluge of new issues; Leggett, MetLife tighten
|
8/8/2012 | CVIG | S&P rates Baxter notes A+
|
8/6/2012 | CVIG | Baxter International files automatic shelf registration covering debt
|
8/3/2012 | CVIG | Fitch gives Baxter A
|
7/27/2012 | CVIG | Fitch affirms Baxter
|
2/16/2012 | CVIG | Fitch affirms Baxter
|
12/14/2011 | CVIG | Moody's rates Baxter notes A3
|
12/14/2011 | CVIG | S&P rates Baxter notes A+
|
12/14/2011 | CVIG | Fitch rates Baxter notes A
|
12/14/2011 | IG | New Issue: Baxter sells upsized $500 million 1.85% five-year notes at Treasuries plus 100 bps
|
12/14/2011 | IG | Market Commentary: Baxter International sells debt to high demand; Morgan Stanley, Best Buy widen in trading
|
8/2/2011 | SP | New Issue: Credit Suisse prices $24.64 million 7% equity-linked notes linked to Baxter International
|
3/3/2011 | CVIG | Fitch affirms Baxter
|
5/7/2010 | CVIG | Moody's: Baxter unchanged
|
5/7/2010 | IG | Moody's: CareFusion unchanged
|
5/6/2010 | CV | S&P: Baxter view to stable
|
5/6/2010 | IG | S&P: Baxter view down to stable
|
3/5/2010 | IG | Market Commentary: Masco sells split-rated bonds, coming week seen busy; Masco gains, recent new deals firm
|
3/4/2010 | IG | Market Commentary: Baxter, Teco, Johnson Controls price on good tone; little movement in secondary; Dow wider
|
3/4/2010 | CVIG | Fitch rates Baxter notes A
|
3/4/2010 | CVIG | S&P rates Baxter notes A+
|
3/4/2010 | CVIG | Moody's rates Baxter notes A3
|
3/4/2010 | IG | New Issue: Baxter International sells $600 million three-, 10-year senior notes
|
8/17/2009 | IG | Market Commentary: Baxter, MeadWestvaco, HSBC Finance offer notes; new industrials improve, financials struggle
|
8/17/2009 | CVHY | S&P gives Baxter notes A+
|
8/17/2009 | CVHY | Fitch rates Baxter notes A
|
8/17/2009 | IG | New Issue: Baxter International prices $500 million 4.5% 10-year notes at Treasuries plus 105 bps
|
7/31/2009 | CVIG | Baxter International files automatic shelf for debt securities
|
3/5/2009 | CVIG | Fitch affirms Baxter
|
2/24/2009 | IG | Market Commentary: Noble Energy, Woodside bring $1 billion each; Baxter trades well; financials weaker but rebound
|
2/23/2009 | CVIG | S&P assigns Baxter notes A+
|
2/23/2009 | CVIG | Fitch gives Baxter notes A
|
2/23/2009 | IG | New Issue: Baxter sells $350 million 4% five-year notes at Treasuries plus 222 bps
|
2/23/2009 | IG | Market Commentary: HP, Baxter, Waste Management, Western Union, Arizona Public sell bonds; new issues see little gain
|
10/24/2008 | CVIG | S&P: Baxter outlook positive
|
5/19/2008 | IG | Market Commentary: PepsiCo, Lexmark, Kraft, Genworth, Baxter, HSBC, ArcelorMittal join new deal surge
|
5/19/2008 | IG | New Issue: Baxter prices $500 million 5.375% 10-year notes at Treasuries plus 158 bps
|
5/19/2008 | IG | S&P rates Baxter notes A+
|
5/19/2008 | IG | S&P rates Baxter notes A+
|
5/19/2008 | IG | Moody's gives Baxter A3
|
5/19/2008 | IG | Fitch gives Baxter notes A
|
3/4/2008 | IG | Fitch affirms Baxter
|
12/4/2007 | IG | S&P assigns Baxter notes A+
|
12/4/2007 | IG | Moody's lifts Baxter, rates notes A3
|
12/4/2007 | IG | Fitch rates Baxter notes A
|
12/4/2007 | IG | Market Commentary: Transocean's $2.5 billion, United Technologies' $1 billion lead emerging backlog; tone softens
|
12/4/2007 | IG | New Issue: Baxter International prices $500 million 6.25% 30-year notes at Treasuries plus 188 bps
|
11/15/2007 | IG | S&P lifts Baxter
|
11/9/2007 | CVIG | Moody's may upgrade Baxter
|
7/26/2007 | CV | S&P: Baxter unaffected
|
4/20/2007 | CV | Moody's ups Baxter outlook to positive
|
3/16/2007 | CV | Fitch lifts Baxter
|
3/13/2007 | CV | S&P: No change for Baxter
|
11/14/2006 | BT | Market Commentary: Acambis plunges on surprise loss of new U.S. vaccine contract bid; World Heart lower; Anadys better
|
11/8/2006 | BTCV | S&P boosts Baxter
|
10/19/2006 | BT | Baxter's net income grows to $374 million, ends Q3 with $2.1 billion of cash
|
10/3/2006 | BKBT | Baxter Transfusion Therapies to get new facility via Morgan Stanley, Citi
|
8/4/2006 | BT | New Issue: Baxter sells upsized $600 million 10-year senior notes to yield 5.943% via Goldman, JPMorgan
|
8/4/2006 | BTCV | S&P gives Baxter International notes A-
|
8/4/2006 | BTCV | S&P gives Baxter International notes A-
|
8/3/2006 | BTCV | Moody's rates Baxter notes Baa1
|
8/3/2006 | BTCV | Fitch rates Baxter notes A-
|
8/2/2006 | BT | Baxter files automatic debt shelf
|
8/2/2006 | BTCV | S&P puts Baxter International on positive watch
|
8/1/2006 | BT | Baxter, Innovata get FDA approval for Adept adhesion reduction solution
|
7/20/2006 | BT | Baxter reports second-quarter operating income up 21% at $373 million
|
7/5/2006 | BT | Baxter starts cell-based flu study
|
6/30/2006 | BTCV | S&P: Baxter unchanged
|
6/29/2006 | BT | Baxter: court accepts company's remediation plan for Colleague and Syndeo infusion pumps
|
6/15/2006 | BT | Baxter gets tentative FDA approval for anti-nausea medicine
|
6/1/2006 | BT | Innovata gets FDA approvable letter for Adept adhesion reduction solution
|
5/19/2006 | BT | Acambis, Baxter oppose European MVA patent for smallpox
|
5/18/2006 | BT | Baxter, Jerini to develop non-intravenous hemophilia therapy
|
5/17/2006 | BT | Gambro, Baxter to research seven-day platelet study
|
5/12/2006 | BTCV | Fitch upgrades Baxter
|
5/9/2006 | BT | FDA approves Baxter's Ultra-High dosage strength of Advate for hemophilia A
|
5/4/2006 | BT | Baxter to collaborate in development of cell-culture flu vaccine
|
4/20/2006 | BT | Baxter first-quarter earnings up 26% to $282 million
|
4/18/2006 | BT | Baxter to launch new Aviva line of IV solutions
|
3/23/2006 | BT | Baxter begins marketing generic azithromycin antibiotic for injection
|
3/7/2006 | BT | Baxter begins phase 2 adult stem cell trial in patients with coronary artery disease
|
2/24/2006 | BT | Baxter gets U.K. contract to produce stockpile of H5N1 flu vaccine
|
2/15/2006 | BT | Baxter's board authorizes $1.5 billion share repurchase program
|
2/13/2006 | BT | Cerus obtains rights to Intercept Blood System from Baxter
|
2/8/2006 | BT | Halozyme, Baxter study of Hylenex shows positive results
|
1/25/2006 | BT | Baxter receives EU authorization for Kiovig to treat immunodeficiencies
|
12/9/2005 | BT | Baxter to market Halozyme's Hylenex in Europe
|
12/5/2005 | BT | Halozyme gets FDA OK for Hylenex; Baxter preps for launch
|
11/18/2005 | BT | Baxter receives FDA clearance for seven-day storage of platelets collected with its Amicus device
|
11/17/2005 | BT | Baxter, Kuros sign product license, collaboration agreement
|
11/17/2005 | BT | S&P: Baxter unaffected
|
11/10/2005 | BTCV | Fitch rates Baxter notes BBB+
|
9/28/2005 | CV | Fitch rates Baxter notes BBB+
|
9/26/2005 | BT | Baxter estimates raised by Bear Stearns
|
9/14/2005 | CV | Fitch ups Baxter view to positive
|
9/1/2005 | BTCV | S&P ups Baxter view to stable
|
8/16/2005 | BT | Market Commentary: Kosan retreats further after pulling follow-on; Nektar slips; Acambis off, Electro-Optical IPO seen delayed
|
7/22/2005 | BT | Baxter price target upped by Bear Stearns
|
3/15/2005 | CV | S&P: Baxter unaffected
|
10/8/2004 | CV | S&P rates Baxter loan A-
|
9/8/2004 | CV | S&P affirms Baxter
|
8/20/2004 | CV | Fitch lowers Baxter rating
|
7/23/2004 | CV | S&P may cut Baxter ratings
|
5/27/2004 | CV | S&P: Baxter unaffected
|
5/12/2004 | CV | Moody's cuts Baxter
|
3/19/2004 | CV | New Issue: Goldman Sachs prices $5 million 5.25% notes exchangeable for Baxter
|
1/13/2004 | CV | S&P cuts Baxter International ratings
|
8/5/2003 | CV | Market Commentary: Further cheapening noted, but many buyers waiting in wings; new deal slate remains active
|
7/16/2003 | CV | Moody's cuts Baxter outlook
|
7/3/2003 | CV | S&P rates Yahoo convert BB+
|
3/5/2003 | CV | Fitch rates Watson convert BBB-
|
12/13/2002 | CV | Market Commentary: Market treads water while stocks, credit spreads flounder
|
12/12/2002 | CV | New Issue: Baxter upsized $1.1 billion mandatory convertibles yield 7.0%, up 24%
|
12/12/2002 | CV | Market Commentary: Ciena boosts telecom names; market trades sideways amid spate of last-minute new deals
|
12/11/2002 | CV | Baxter ups mandatory to $1.1 billion from $850 million, leaves guidance unchanged
|
12/11/2002 | CV | S&P rates Baxter mandatory A
|
12/11/2002 | CV | Market Commentary: Slow day despite new deals; Baxter gets upsized but new Navistar sinks out of the gate
|
12/10/2002 | CV | Baxter $850 million mandatory at 7.0% to 7.5% yield, up 20% to 24%
|
12/10/2002 | CV | Fitch rates Baxter mandatory A
|
12/10/2002 | CV | Market Commentary: Navistar, Baxter launch deals; volume better on new issues, after Fed leaves rates alone
|
12/3/2002 | CV | S&P upgrades Standard Commercial
|
9/13/2002 | CV | Market Commentary: Slow session compounded by war concerns, conflicting data
|
7/18/2002 | CV | S&P says Baxter charge raises questions
|
7/18/2002 | CV | Market Commentary: Baxter, XL Capital hold up nicely against huge stock declines
|
6/10/2002 | CV | Fitch cuts Tyco ratings to junk
|
5/30/2002 | CV | Baxter puts sure to be recalled; upcoming Novellus, Household bonds likely to get sweeteners
|
5/29/2002 | CV | Baxter adds last-minute put sweetener; Deutsche expects puts to be withdrawn
|
5/17/2002 | CV | Deutsche recommends US Bancorp, Baxter, Medtronic, HCC, Markel as put sweetener trading ideas
|
5/16/2002 | CV | Market Commentary: LifePoint prices drive-by deal in slow session
|
11/6/2001 | CV | Market Commentary: Convertible market gains with stocks on rate cut, new deals
|
11/5/2001 | CV | Market Commentary: Rallying techs aid convertibles
|